PONTI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.093
EU - Europa 9.496
AS - Asia 8.959
SA - Sud America 1.374
Continente sconosciuto - Info sul continente non disponibili 424
AF - Africa 192
OC - Oceania 23
Totale 44.561
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.519
GB - Regno Unito 3.260
SG - Singapore 2.874
IT - Italia 2.222
CN - Cina 2.146
HK - Hong Kong 1.101
BR - Brasile 1.048
VN - Vietnam 952
SE - Svezia 907
DE - Germania 768
FI - Finlandia 510
BD - Bangladesh 487
UA - Ucraina 481
RU - Federazione Russa 368
CA - Canada 355
TR - Turchia 347
FR - Francia 346
IN - India 214
KR - Corea 192
BG - Bulgaria 169
MX - Messico 142
ID - Indonesia 129
AR - Argentina 104
IQ - Iraq 90
NL - Olanda 86
JP - Giappone 71
IE - Irlanda 60
ZA - Sudafrica 57
EC - Ecuador 53
PL - Polonia 51
ES - Italia 48
CO - Colombia 42
AE - Emirati Arabi Uniti 41
PK - Pakistan 40
MY - Malesia 37
VE - Venezuela 33
CL - Cile 31
MA - Marocco 29
BE - Belgio 28
LT - Lituania 25
SA - Arabia Saudita 25
JO - Giordania 24
EG - Egitto 23
KE - Kenya 23
PH - Filippine 23
UZ - Uzbekistan 23
AT - Austria 22
PY - Paraguay 22
TH - Thailandia 21
AU - Australia 20
CH - Svizzera 20
PE - Perù 19
RO - Romania 19
NP - Nepal 17
CZ - Repubblica Ceca 15
CR - Costa Rica 14
AZ - Azerbaigian 13
TN - Tunisia 13
DZ - Algeria 12
HU - Ungheria 12
PT - Portogallo 12
DO - Repubblica Dominicana 11
IR - Iran 11
JM - Giamaica 11
KZ - Kazakistan 11
PA - Panama 11
BO - Bolivia 10
EU - Europa 10
IL - Israele 10
LU - Lussemburgo 10
NO - Norvegia 9
PS - Palestinian Territory 9
UY - Uruguay 9
NG - Nigeria 8
DK - Danimarca 7
LB - Libano 7
RS - Serbia 7
BH - Bahrain 6
AL - Albania 5
ET - Etiopia 5
GT - Guatemala 5
HN - Honduras 5
KG - Kirghizistan 5
MD - Moldavia 5
OM - Oman 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
GE - Georgia 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
AO - Angola 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
HR - Croazia 3
LK - Sri Lanka 3
LV - Lettonia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
Totale 44.099
Salva come PNG Salva come JPEG
Città #
Fairfield 2.539
Southend 2.473
Ashburn 2.134
Santa Clara 1.927
Singapore 1.676
Woodbridge 1.579
Houston 1.181
Hong Kong 1.088
Seattle 982
Chandler 923
Wilmington 851
Jacksonville 833
Cambridge 814
Dearborn 786
Ann Arbor 661
San Jose 626
Chicago 609
Nyköping 543
Beijing 500
Los Angeles 484
Hefei 472
London 425
Helsinki 353
Council Bluffs 344
Ho Chi Minh City 285
Modena 284
Salt Lake City 248
The Dalles 229
Hanoi 228
New York 221
San Diego 209
Princeton 203
Ottawa 195
Milan 191
Izmir 188
Seoul 180
Sofia 167
Eugene 155
Rome 148
Shanghai 139
Buffalo 135
Lauterbourg 127
Tampa 123
Dallas 116
Elk Grove Village 115
Moscow 97
Orem 93
São Paulo 89
Jakarta 88
Bremen 81
Frankfurt am Main 75
Munich 74
Sterling 72
Lancaster 62
Phoenix 61
Dublin 57
Redwood City 54
Columbus 52
Grafing 51
Da Nang 47
Tokyo 47
Bologna 44
Dong Ket 44
Haiphong 43
Toronto 42
Atlanta 41
Montreal 41
Denver 40
Des Moines 40
Warsaw 39
Guangzhou 38
Miami 38
Brooklyn 36
Rio de Janeiro 36
Turin 36
Boardman 35
Norwalk 35
Fremont 33
Chennai 32
Detroit 32
Belo Horizonte 30
Mexico City 30
Naples 30
Palermo 28
Baghdad 27
Dulles 27
New Delhi 25
Miano 24
Redondo Beach 24
Dongguan 23
Kunming 23
Nanjing 23
Pittsburgh 23
Cagliari 22
Curitiba 22
Quito 22
San Mateo 22
Stockholm 22
Mumbai 21
San Francisco 21
Totale 31.003
Salva come PNG Salva come JPEG
Nome #
Mutazioni somatiche di BRAF in pazienti affetti da melanoma maligno metastatico ed efficacia clinica degli approcci terapeutici a bersaglio molecolare con inibitori di BRAF 617
Neoplasie maligne e benigne associate al melanoma multiplo: coinvolgimento di MITF, PTEN and CDKN2A nella cancerogenesi melanocitaria multipla. 583
Wall paintings facies and their possible genetic correlates in the ancient Pompeii: A bio-anthropologic message from the past? 469
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 461
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 456
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA) 453
The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients 451
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 445
Reticular grey-blue areas of regression as a dermoscopic marker of melanoma in situ. 442
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 438
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 427
Brooke-Spiegler syndrome: Report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes 418
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLD mutation in Brenner tumor 415
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 409
"Collision" metastasis from unknown primary squamous cell carcinoma and papillary microcarcinoma of thyroid presenting as lateral cervical cystic mass 404
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 402
Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients 400
Caso di Neurofibromatosi diagnosticata a 71 anni 395
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 395
Aetiology of colorectal cancer and relevance of monogenic inheritance. 381
Multiphoton laser tomography and fluorescence lifetime imaging of melanoma: morphologic features and quantitative data for sensitive and specific non-invasive diagnostics. 381
A novel CYLD germline mutation in Brooke-Spiegler syndrome. 379
Congenital Glioblastoma multiforme and eruptive disseminated Spitz nevi 377
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 371
Diagnostic and pathogenetic role of café-au-lait macules in nevoid basal cell carcinoma syndrome 371
Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer 370
Seminal Cell-Free DNA Assessment as a Novel Prostate Cancer Biomarker 365
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 365
Variegated Dermoscopy of in situ Melanoma. 364
Ameloblastoma: A neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome 363
Hereditary trichilemmal cysts: a proposal for the assessment of diagnostic clinical criteria 363
M09Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 362
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 361
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome. 361
BRAF ,NRASandC-KITAdvanced Melanoma: Clinico-pathological Features, Targeted-Therapy Strategies and Survival 351
Hypomelanosis of Ito with a trisomy 2 mosaicism: a case report 349
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 348
Giant elephantiasis neuromatosa in the setting of neurofibromatosis type 1: A case report 347
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis 345
High Magnification Digital Dermoscopy of Basal Cell Carcinoma: A Single-centre Study on 400 cases. 340
Unicystic ameloblastoma associated with the novel K729M PTCH1 mutation in a patient with nevoid basal cell carcinoma (Gorlin) syndrome. 338
The impact of histopathologic diagnosis on the proper management of testis neoplasms. 337
Grey-blue regression in melanoma in situ-evaluation on 111 cases. 337
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. 336
Skeletal and cranio-facial signs in Gorlin syndrome from ancient Egypt to the modern age: Sphenoid asymmetry in a patient with a novel PTCH1 mutation 336
Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome 335
PTCH1 germline mutations and the basaloid follicular hamartoma values in the tumor spectrum of basal cell carcinoma syndrome (NBCCS) 334
Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology 333
Biomarkers associated with COVID-19 disease progression 332
Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy 331
Dermoscopy of small melanomas: just a miniaturized dermoscopy? 329
Fluorescence in-situ hybridization and dermoscopy in the assessment of controversial melanocytic tumors. 326
Confocal microscopy characterization of BRAFV600E mutated melanomas 326
NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies 325
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 324
Muir-Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients 324
Skeletal stigmata as keys to access to the composite and ancient Gorlin-Goltz syndrome history: The Egypt, Pompeii and Herculaneum lessons 324
BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features? 322
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 319
Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanomas 316
Microsatellite instability and colorectal cancer prognosis. 309
Mismatch Repair Gene Deficiency and Genetic Anticipation in Lynch Syndrome 304
Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes. 303
Desmoplastic melanoma: a challenge for the oncologist 298
Oral mucosal stigmata in hereditary-cancer syndromes: From germline mutations to distinctive clinical phenotypes and tailored therapies 297
Seminal cell free DNA concentration levels discriminate between prostate cancer and benign prostatic hyperplasia 296
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 295
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 295
Seminal cell-free DNA assessment as a novel prostate cancer biomarker 290
Fibroepithelioma of Pinkus: Solitary tumor or sign of a complex gastrointestinal syndrome 288
Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma 286
Is confocal microscopy a valuable tool in diagnosing nodular lesions? A study on 140 cases. 285
Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. 283
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 279
Diagnosis of BCC by multiphoton laser tomography. 278
Can noninvasive imaging tools potentially predict the risk of ulceration in invasive melanomas showing blue and black colors? 276
Role of microsatellite instability, immunohistochemistry and Mismatch Repair germline aberrations in immunosuppressed transplant patients: a phenocopy dilemma in Muir-Torre Syndrome. 275
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 274
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 273
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 272
The dermoscopic variability of pigment network in melanoma in situ. 266
Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 265
Seminal cell-free DNA molecular profile as a novel diagnostic and prognostic prostate cancer biomarkers 263
Are the neck malignant melanomas different from the ones affecting the head? Clinicopathologic, dermoscopic and prognostic findings 263
High-resolution imaging of basal cell carcinoma: a comparison between multiphoton microscopy with fluorescence lifetime imaging and reflectance confocal microscopy. 262
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 261
Biological characterization of mucinous carcinoma of the colon and rectum 260
Multiphoton laser tomography and fluorescence lifetime imaging of basal cell carcinoma: morphologic features for non-invasive diagnostics 259
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 258
Microsatellite instability, immunohistochemistry and germline mismatch repair gene mutations for the diagnosis of Muir-Torre syndrome in immunosuppressed patients 258
Relationship between histological and computer based assessment of melanoma diameter and thickness in head & neck vs. trunk melanoma. 256
Stem cell properties in cell cultures from different stage of melanoma progression. 248
High resolution diagnosis of common nevi by multiphoton laser tomography and fluorescence lifetime imaging. 247
The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutations. 247
Proteomic Analysis of PTCH1+/- Fibroblast Lysate and Conditioned Culture Media Isolated from the Skin of Healthy Subjects and Nevoid Basal Cell Carcinoma Syndrome Patients. 247
Distinctive clinical and dermoscopic features of BRAFp.V600K mutated melanomas. 246
Erratum: Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanoma (Disease Markers) 246
Alternative marker panel for Microsatellite Instability analysis in deection of contitutional MLH1 and MSH2 mutations. 243
Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report 242
Muir-Torre Syndrome and founder Mismatch Repair genes mutations: A long gone historical genetic challenge 240
Totale 33.511
Salva come PNG Salva come JPEG
Categoria #
all - tutte 167.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 167.670
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.046 0 412 347 182 73 176 175 184 360 238 553 346
2022/20232.776 357 345 210 236 329 383 59 255 316 51 133 102
2023/20241.862 86 90 129 174 383 193 193 216 53 48 100 197
2024/20256.728 193 63 92 405 1.297 1.049 455 429 707 365 677 996
2025/202613.190 637 376 887 1.800 2.756 810 1.377 615 1.183 1.035 1.017 697
2026/2027590 559 31 0 0 0 0 0 0 0 0 0 0
Totale 44.561